30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Providers & Services

Enhabit Inc (EHAB)

Track

The most recent insider transactions at Enhabit Inc. occurred on March 11, 2026, involving sales by Collin McQuiddy, Chief Accounting Officer. Prior to this, on March 10, 2026, Julie Diane Jolley, EVP of Home Health Operations, also made sales. Earlier transactions in 2024 and 2025 were predominantly buys from multiple insiders, including Chief Financial Officer Ryan Solomon and Jeffrey Bolton.
Stock chart
Ticker: EHAB Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
McQuiddy Collin
Chief Accounting Officer
2 sales — total 38,194 USD
Sale 11 Mar 2026
Value US$2,981,430.30 | Price 417.87 | Shares 24,976
Proposed sale 11 Mar 2026
Value US$2,085,242.74 | Price 478.76 | Shares 51,972
Sale 10 Mar 2026
Value US$3,955,325.78 | Price 132.60 | Shares 58,696
Proposed sale 10 Mar 2026
Value US$1,667,240.37 | Price 458.37 | Shares 25,903
Sale 9 Mar 2026
Value US$38,068.59 | Price 13.63 | Shares 2,793
Buy 8 Aug 2025
Value US$76,400.00 | Price 7.64 | Shares 10,000
Sale 10 Mar 2025
Value US$9,403.68 | Price 8.58 | Shares 1,096
Buy 12 Dec 2024
Value US$34,760.00 | Price 8.69 | Shares 4,000
Buy 10 Dec 2024
Value US$132,150.00 | Price 8.81 | Shares 15,000
Buy 12 Nov 2024
Value US$22,800.00 | Price 7.60 | Shares 3,000
Buy 8 Nov 2024
Value US$49,347.27 | Price 7.77 | Shares 6,351
Buy 8 Nov 2024
Value US$5,029.75 | Price 7.75 | Shares 649
Buy 22 Aug 2024
Value US$40,050.00 | Price 8.01 | Shares 5,000
Buy 9 Aug 2024
Value US$41,450.00 | Price 8.29 | Shares 5,000
Buy 8 Aug 2024
Value US$17,200.00 | Price 8.60 | Shares 2,000
Buy 17 May 2024
Value US$83,300.00 | Price 8.33 | Shares 10,000
Buy 14 May 2024
Value US$18,000.00 | Price 9.00 | Shares 2,000
Buy 10 May 2024
Value US$82,400.00 | Price 8.24 | Shares 10,000
Buy 10 May 2024
Value US$82,400.00 | Price 8.24 | Shares 10,000
Sale 1 Mar 2024
Value US$5,585.54 | Price 8.81 | Shares 634
Buy 26 May 2023
Value US$23,220.00 | Price 11.61 | Shares 2,000
Buy 22 May 2023
Value US$119,800.00 | Price 11.98 | Shares 10,000
Buy 18 May 2023
Value US$24,822.00 | Price 11.82 | Shares 2,100
Buy 18 May 2023
Value US$119,900.00 | Price 11.99 | Shares 10,000
Buy 17 May 2023
Value US$23,600.00 | Price 11.80 | Shares 2,000
Buy 18 Nov 2022
Value US$12,690.00 | Price 12.69 | Shares 1,000
Buy 9 Nov 2022
Value US$25,500.00 | Price 12.75 | Shares 2,000
Buy 8 Nov 2022
Value US$25,780.00 | Price 12.89 | Shares 2,000
Buy 8 Nov 2022
Value US$5,780.82 | Price 13.57 | Shares 426
Buy 7 Nov 2022
Value US$105,327.00 | Price 12.69 | Shares 8,300
Buy 4 Nov 2022
Value US$21,386.00 | Price 12.58 | Shares 1,700
Buy 31 Aug 2022
Value US$24,784.50 | Price 15.99 | Shares 1,550
Buy 19 Aug 2022
Value US$13,483.00 | Price 13.90 | Shares 970
Buy 18 Aug 2022
Value US$82,128.60 | Price 13.62 | Shares 6,030
Buy 17 Aug 2022
Value US$24,995.20 | Price 14.60 | Shares 1,712
Buy 11 Aug 2022
Value US$50,135.00 | Price 13.55 | Shares 3,700
Buy 9 Aug 2022
Value US$413,400.00 | Price 13.78 | Shares 30,000
Buy 9 Aug 2022
Value US$136,400.00 | Price 13.64 | Shares 10,000
Buy 8 Aug 2022
Value US$13,590.00 | Price 13.59 | Shares 1,000
Buy 8 Aug 2022
Value US$20,625.00 | Price 13.75 | Shares 1,500
Buy 4 Aug 2022
Value US$11,740.00 | Price 11.74 | Shares 1,000
Buy 4 Aug 2022
Value US$37,110.00 | Price 12.37 | Shares 3,000
Buy 4 Aug 2022
Value US$175,800.00 | Price 11.72 | Shares 15,000
Buy 3 Aug 2022
Value US$61,065.00 | Price 13.57 | Shares 4,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-11 2026-03-11 S Sale
1.9
McQuiddy Collin

Chief Accounting Officer

Officer
24,976 +45.0%
417.87
US$2,981,430 		24,976 +45.0% 417.87 US$2,981,430
2026-03-11 2026-03-11 PrS Proposed sale
1.9
McQuiddy Collin

Officer

Officer
51,972
478.76
US$2,085,243 		51,972 478.76 US$2,085,243
2026-03-11 2026-03-10 S Sale
Jolley Julie Diane

EVP of Home Health Operations

Officer
58,696 +22.2%
132.60
US$3,955,326 		58,696 +22.2% 132.60 US$3,955,326
2026-03-10 2026-03-10 PrS Proposed sale
Jolley Julie Diane

Officer

Officer
5,586
13.64
US$76,193 		5,586 13.64 US$76,193
2026-03-11 2026-03-09 S Sale
Jolley Julie Diane

EVP of Home Health Operations

Officer
2,793 -2.0%
13.63
US$38,069 		2,793 -2.0% 13.63 US$38,069
2025-08-11 2025-08-08 B Purchase
2.7
Solomon Ryan

Chief Financial Officer

Officer
10,000 +5.5%
7.64
US$76,400 		10,000 +5.5% 7.64 US$76,400
2025-03-10 2025-03-10 S Sale
1.9
McQuiddy Collin

Chief Accounting Officer

Officer
1,096 -100.0%
8.58
US$9,404 		1,096 -100.0% 8.58 US$9,404
2024-12-12 2024-12-12 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
4,000 +4.2%
8.69
US$34,760 		4,000 +4.2% 8.69 US$34,760
2024-12-11 2024-12-10 B Purchase
0.9
MCGUIGAN STUART M
Non-Executive Director
15,000 +47.2%
8.81
US$132,150 		15,000 +47.2% 8.81 US$132,150
2024-11-12 2024-11-12 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
3,000 +3.3%
7.60
US$22,800 		3,000 +3.3% 7.60 US$22,800
2024-11-12 2024-11-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
6,351 +7.5%
7.77
US$49,347 		6,351 +7.5% 7.77 US$49,347
2024-11-12 2024-11-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
649 +0.8%
7.75
US$5,030 		649 +0.8% 7.75 US$5,030
2024-08-23 2024-08-22 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
5,000 +6.8%
8.01
US$40,050 		5,000 +6.8% 8.01 US$40,050
2024-08-12 2024-08-09 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
5,000 +7.3%
8.29
US$41,450 		5,000 +7.3% 8.29 US$41,450
2024-08-12 2024-08-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +3.0%
8.60
US$17,200 		2,000 +3.0% 8.60 US$17,200
2024-05-17 2024-05-17 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
10,000 +23.6%
8.33
US$83,300 		10,000 +23.6% 8.33 US$83,300
2024-05-15 2024-05-14 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
2,000 +7.0%
9.00
US$18,000 		2,000 +7.0% 9.00 US$18,000
2024-05-10 2024-05-10 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
10,000 +31.0%
8.24
US$82,400 		10,000 +31.0% 8.24 US$82,400
2024-05-10 2024-05-10 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
10,000 +31.0%
8.24
US$82,400 		10,000 +31.0% 8.24 US$82,400
2024-03-05 2024-03-01 S Sale
1.7
Langham Ronald Leroy JR

EVP Clinical Excel. & Strategy

Officer
634 -1.1%
8.81
US$5,586 		634 -1.1% 8.81 US$5,586
2023-05-31 2023-05-26 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +11.4%
11.61
US$23,220 		2,000 +11.4% 11.61 US$23,220
2023-05-23 2023-05-22 B Purchase
3.2
SHAW L EDWARD JR
Non-Executive Director
10,000 +34.5%
11.98
US$119,800 		10,000 +34.5% 11.98 US$119,800
2023-05-22 2023-05-18 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
2,100 +15.4%
11.82
US$24,822 		2,100 +15.4% 11.82 US$24,822
2023-05-22 2023-05-18 B Purchase
1.7
Langham Ronald Leroy JR

EVP Clinical Excel. & Strategy

Officer
10,000 +29.1%
11.99
US$119,900 		10,000 +29.1% 11.99 US$119,900
2023-05-18 2023-05-17 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +12.8%
11.80
US$23,600 		2,000 +12.8% 11.80 US$23,600
2022-11-22 2022-11-18 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
1,000 +6.9%
12.69
US$12,690 		1,000 +6.9% 12.69 US$12,690
2022-11-10 2022-11-09 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +15.9%
12.75
US$25,500 		2,000 +15.9% 12.75 US$25,500
2022-11-10 2022-11-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +18.9%
12.89
US$25,780 		2,000 +18.9% 12.89 US$25,780
2022-11-09 2022-11-08 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
426 +5.7%
13.57
US$5,781 		426 +5.7% 13.57 US$5,781
2022-11-08 2022-11-07 B Purchase
3.4
Rush Gregory S
Non-Executive Director
8,300 +100.0%
12.69
US$105,327 		8,300 +100.0% 12.69 US$105,327
2022-11-08 2022-11-04 B Purchase
3.4
Rush Gregory S
Non-Executive Director
1,700 +25.8%
12.58
US$21,386 		1,700 +25.8% 12.58 US$21,386
2022-09-02 2022-08-31 B Purchase
0.7
Brown-Stevenson Tina L.
Non-Executive Director
1,550 +19.1%
15.99
US$24,784 		1,550 +19.1% 15.99 US$24,784
2022-08-22 2022-08-19 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
970 +7.7%
13.90
US$13,483 		970 +7.7% 13.90 US$13,483
2022-08-22 2022-08-18 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
6,030 +91.4%
13.62
US$82,129 		6,030 +91.4% 13.62 US$82,129
2022-08-19 2022-08-17 B Purchase
1.5
Marion Tanya Renee

Chief Human Resources Officer

Officer
1,712 +inf%
14.60
US$24,995 		1,712 +inf% 14.60 US$24,995
2022-08-15 2022-08-11 B Purchase
2.3
ELSON CHARLES M
Non-Executive Director
3,700 +20.1%
13.55
US$50,135 		3,700 +20.1% 13.55 US$50,135
2022-08-10 2022-08-09 B Purchase
2.7
Jacobsmeyer Barbara Ann

President and CEO

Executive Director
30,000 +14.4%
13.78
US$413,400 		30,000 +14.4% 13.78 US$413,400
2022-08-10 2022-08-09 B Purchase
3.2
SHAW L EDWARD JR
Non-Executive Director
10,000 +52.7%
13.64
US$136,400 		10,000 +52.7% 13.64 US$136,400
2022-08-10 2022-08-08 B Purchase
2.4
MAUPIN JOHN E JR D D S
Non-Executive Director
1,000 +6.1%
13.59
US$13,590 		1,000 +6.1% 13.59 US$13,590
2022-08-10 2022-08-08 B Purchase
2.4
CURL YVONNE M
Non-Executive Director
1,500 +9.3%
13.75
US$20,625 		1,500 +9.3% 13.75 US$20,625
2022-08-08 2022-08-04 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
1,000 +15.2%
11.74
US$11,740 		1,000 +15.2% 11.74 US$11,740
2022-08-08 2022-08-04 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
3,000 +66.7%
12.37
US$37,110 		3,000 +66.7% 12.37 US$37,110
2022-08-08 2022-08-04 B Purchase
2.3
LaMonica Susan
Non-Executive Director
15,000 +185.3%
11.72
US$175,800 		15,000 +185.3% 11.72 US$175,800
2022-08-05 2022-08-03 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
4,500 +inf%
13.57
US$61,065 		4,500 +inf% 13.57 US$61,065
Explore more

More insider trading research around Enhabit Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America